Triamcinolone acetonide concentration after filtration of the solvent agent

被引:23
作者
Spandau, UHM
Derse, M
Schmitz-Valckenberg, P
Papoulis, C
Sagstetter, BU
Stiefvater, K
Jonas, JB
机构
[1] Evangel Stift, Dept Ophthalmol, Koblenz, Germany
[2] Univ Hosp Mannheim, Dept Ophthalmol, Mannheim, Germany
[3] Univ Heidelberg, Pharm Fac Clin Med Mannheim, D-6800 Mannheim, Germany
关键词
D O I
10.1016/j.ajo.2004.09.059
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To determine the amount of triamcinolone acetonide and the preservative benzyl alcohol after filtration. DESIGN: Laboratory investigation. METHODS: The probes were prepared by two different hospital pharmacies. The probes of the first pharmacy included 20 probes with 25-mg triamcinolone acetonide, unfiltered (n = 5 probes) or filtered (n = 5), or with 4-mg triamcinolone acetonide, filtered (n = 5) or unfiltered (n = 5). The probes for the second pharmacy were filtered (n = 3) probes of 25-mg triamcinolone acetonide. RESULTS: For the probes of the first pharmacy, triamemolone acetonide dosages were 2.4 +/- 0.8 mg, 3.1 +/- 0.6 mg, 12.8 +/- 0.7 mg, and 23.4 +/- 2.3 mg, respectively, for the filtered 4-mg probes, unfiltered 4-mg probes, filtered 25-mg probes, and unfiltered 25-mg probes, respectively. For the second pharmacy, mean triamcinolone acetonide dosage was 23.8 +/- 0.6 mg for the 25-mg filtered probes and contained benzyl alcohol in a mean concentration of 0.0013 +/- 0.0001 mg/0.1 ml. CONCLUSIONS: Depending on the method employed and the pharmacy, preparation of triamcinolone acetonide including filtration of the solvent agent leads to a marked inter-pharmacy variation and a relatively low intrapharmacy variation in the reduction of triamcinolone acetonide dosage. (Am J Ophthalmol 2005;139: 712 713. (c) 2005 by Elsevier Inc. All rights reserved).
引用
收藏
页码:712 / 713
页数:2
相关论文
共 5 条
[1]   A Randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration - One year results [J].
Gillies, MC ;
Simpson, JM ;
Luo, W ;
Penfold, P ;
Hunyor, ABL ;
Chua, W ;
Mitchell, P ;
Billson, F .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) :667-673
[2]  
Jonas JB, 2003, ARCH OPHTHALMOL-CHIC, V121, P57
[3]   Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema [J].
Jonas, JB ;
Söfker, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (03) :425-427
[4]   Intravitreal triamcinolone acetonide for exudative age related macular degeneration [J].
Jonas, JB ;
Kreissig, I ;
Hugger, P ;
Sauder, G ;
Panda-Jonas, S ;
Degenring, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (04) :462-468
[5]   Intravitreal injection of triamcinolone for diffuse macular edema [J].
Rodríguez-Coleman, H ;
Yuan, P ;
Kim, H ;
Gravlin, L ;
Srivastava, S ;
Csaky, KG ;
Robinson, MR .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (07) :1085-1086